Eurafric Pharma Limtied Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 77.40%
- Ebitda 84.08%
- Net Worth -7.02%
- Total Assets -68.65%
About Eurafric Pharma Limtied
Eurafric Pharma Private Limtied (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 August 2008 and has a history of 16 years and five months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nilesh Pawar, Alfred Spinnler, and Vasanti Vasant serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397MH2008PTC185719
-
Company No.
185719
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Aug 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Eurafric Pharma Limtied?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Pawar
|
Managing Director | 12-Aug-2008 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alfred Spinnler
|
Director | 01-Jul-2010 | Current |
|
Vasanti Vasant
|
Director | 20-Oct-2010 | Current |
Financial Performance of Eurafric Pharma Limtied.
Eurafric Pharma Private Limtied, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 77.4% increase in profit. The company's net worth dipped by a decrease of 7.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eurafric Pharma Limtied?
In 2017, Eurafric Pharma Limtied had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eurafric Pharma Limtied?
Unlock and access historical data on people associated with Eurafric Pharma Limtied, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eurafric Pharma Limtied, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurafric Pharma Limtied's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
